Validation assessment of risk tools to predict outcome after thrombolytic therapy for acute ischemic stroke

Thrombolytic therapy generally improves clinical outcome after acute ischemic stroke, but the decision to administer thrombolytics may be challenging because of hemorrhagic complications and poor response in some patients [1–4]. Many models for risk stratification of thrombolytic treatment have been developed to support the clinician in this complex decision-making process.

Source: Clinical Neurology and Neurosurgery - August 14, 2014 Category: Neurosurgery Authors: Robbert-Jan Van Hooff, Koenraad Nieboer, Ann De Smedt, Maarten Moens, Peter Paul De Deyn, Jacques De Keyser, Raf Brouns Source Type: research